GC Pharma is pleased to offer its state-of –the-art manufacturing facilities for the production of sterile vial and pre-filled syringe drug products. Production is split between two key sites, Ochang and Hwasun. Read below for more information about the sites.
Ochang South Korea
Labelling and Packaging
W&FF Plant is newly constructed (2019) and can offer vial filling on an isolator line - the safest method for type of filling sterile vial based drug products. It also has the latest automated visual inspection machinery, including 100% IPC container closure integrity testing and foreign body detection. Its barcode controlled warehouse in integrated into every floor, giving it the most innovative Materials Management Systems, which ensure highly efficient and organised warehousing. The W&FF Plant is suitable for deactivated vaccines, recombinant proteins, and mRNA based drug products.
WHO Vaccine Plant
Hwasun South Korea
Drug Substances and
Hwasun WHO Vaccine Plant is GC Pharma’s dedicated vaccine manufacturing site, which was been pre-approved by the WHO for the production GC FluTM, GC Pharma’s quadrivalent influenza vaccine. The site has the capability to produce live as well as deactivated vaccines in vial and pre-filled syringe formats. Fill finish facilities include O-RABS filling lines, automated visual inspection, and automated labelling and secondary packaging lines.